IMSC Financials 07/16/2014 06:44:55
Implant Sciences Corp.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 12,017 3,406 6,652 3,474
Cost of Revenue 8,588 2,407 4,011 2,229
Gross Profit 3,429 999 2,641 1,245
Operating Expenses
Research and Development 4,754 3,180 2,719 2,399
Sales, General and Admin. 20,630 8,575 5,746 4,422
Non-Recurring Items - - - 3,136
Other - - - -
Operating Income (21,955) (10,756) (5,824) (3,328)
Income From Continuing Operations
Add'l Income/Expense Items 2 4 (7,304) (4,275)
Earnings Before Interest and Tax (21,953) (10,752) (13,128) (12,987)
Interest Expense 5,401 3,884 2,426 2,412
Earnings Before Tax (27,354) (14,636) (15,554) (15,399)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (27,354) (14,636) (15,554) (15,399)
Non Recurring Events
Discontinued Operations - - - (124)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (27,354) (14,636) (15,554) (15,523)
Preferred Stock and Other Adjustments - - - (329)
Net Income Applicable to Common Shareholders (27,354) (14,636) (15,554) (15,852)